Schedule 13G/A
APLT Schedule 13G/A filing by T. Rowe Price Investment Management
T. Rowe Price Investment Management reported beneficial ownership of 18.7M shares, representing 13.2% of APPLIED THERAPEUTICS INC in this filing.
FiledAug 14, 2025
Ownership dateJun 30, 2025
Reported shares18.7M
Reported ownership13.2%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
18.7M
Shared voting power
18.7M
Sole dispositive power
18.7M
Shared dispositive power
18.7M
Compared with the prior filing
How the reported position changed
This compares the current filing with the previous tracked Schedule 13 filing from the same reporting CIK for APLT. A change between filings does not by itself establish when shares were bought or sold.
Previous filingMay 7, 2025
Reported share change+8,303,400
Ownership percentage change+1.2 pts
| Previous filing | This filing | |
|---|---|---|
| Reported shares | 10.4M | 18.7M |
| Reported ownership | 12% | 13.2% |
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- T. Rowe Price Investment Management
- CIK
- CIK0001897612
- Accession
- 0001897612-25-000375
- Form
- Schedule 13G/A
Read the filing in context